{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:52:04Z","timestamp":1761533524266,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":5242,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1111\/j.1538-7836.2008.03036.x","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T23:26:42Z","timestamp":1211498802000},"page":"1385-1392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protective effects of triflusal on secondary thrombus growth and vascular cyclooxygenase\u20102"],"prefix":"10.1016","volume":"6","author":[{"given":"X.","family":"DURAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"S\u00c1NCHEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"VILAHUR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"BADIMON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0010","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/01.CIR.78.6.1431","article-title":"Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation","volume":"78","author":"Badimon","year":"1988","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI114277","article-title":"Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model","volume":"84","author":"Badimon","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/01.ATV.10.2.306","article-title":"Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth","volume":"10","author":"Lassila","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot\u2010bound thrombin is protected from inhibition by heparin\u2010antithrombin III but is susceptible to inactivation by antithrombin III\u2010independent inhibitors","volume":"86","author":"Weitz","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003495-200565040-00003","article-title":"Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke","volume":"65","author":"Weinberger","year":"2005","journal-title":"Drugs"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2008.03036.x_bb0035","doi-asserted-by":"crossref","first-page":"483S","DOI":"10.1378\/chest.126.3_suppl.483S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"3","author":"Albers","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0040","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS\u20102","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.410420606","article-title":"A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin","volume":"42","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high\u2010risk patients (MATCH): randomised, double\u2010blind, placebo\u2010controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0055","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/01.WNL.0000113757.34662.AA","article-title":"Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study","volume":"62","author":"Culebras","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","article-title":"Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double\u2010blind, multicenter trial","volume":"34","author":"Matias\u2010Guiu","year":"2003","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0065","first-page":"CD004296","article-title":"Triflusal for preventing serious vascular events in people at high risk","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(67)91658-3","article-title":"Impaired platelet\u2010connective\u2010tissue reaction in man after aspirin ingestion","volume":"2","author":"Weiss","year":"1967","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)\u20102: the human pharmacology of a selective inhibitor of COX\u20102","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0080","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00003495-199855060-00011","article-title":"Triflusal","volume":"55","author":"McNeely","year":"1998","journal-title":"Drugs"},{"issue":"Suppl. I","key":"10.1111\/j.1538-7836.2008.03036.x_bb0085","doi-asserted-by":"crossref","first-page":"I23","DOI":"10.1016\/S1520-765X(01)90103-8","article-title":"Antiplatelet drugs in the treatment of acute coronary syndromes: focus on ciclyogenase inhibitors","volume":"3","author":"Cruz\u2010Fernandez","year":"2001","journal-title":"Eur Heart J Suppls"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0609.1988.tb00829.x","article-title":"Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients","volume":"40","author":"De la Cruz","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00210-004-1001-y","article-title":"Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia\u2010reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids","volume":"371","author":"Gonzalez\u2010Correa","year":"2005","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0100","first-page":"706","article-title":"Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111\u2010labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene","volume":"110","author":"Badimon","year":"1987","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0105","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/01.CIR.90.5.2432","article-title":"Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy","volume":"90","author":"Meyer","year":"1994","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.CIR.97.7.681","article-title":"Dissolution of mural thrombus by specific thrombin inhibition with r\u2010hirudin: comparison with heparin and aspirin","volume":"97","author":"Meyer","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0115","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.99.14.1780","article-title":"Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions","volume":"99","author":"Badimon","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0160-5402(82)90039-0","article-title":"Intravenous arachidonate\u2010induced respiratory distress: comparative study of three in vivo models for the measurement of antithrombotic activity","volume":"7","author":"Garcia Rafanell","year":"1982","journal-title":"J Pharmacol Methods"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.atherosclerosis.2007.06.002","article-title":"Lysyl oxidase (LOX) down\u2010regulation by TNFalpha: a new mechanism underlying TNFalpha\u2010induced endothelial dysfunction","volume":"196","author":"Rodriguez","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0130","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1161\/01.CIR.0000041434.28573.0B","article-title":"Low\u2010density lipoprotein upregulates low\u2010density lipoprotein receptor\u2010related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein\u20102\u2010dependent mechanism","volume":"106","author":"Llorente\u2010Cortes","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0135","first-page":"e25","article-title":"Heart disease and stroke statistics\u20132008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"issue":"Suppl 3A","key":"10.1111\/j.1538-7836.2008.03036.x_bb0140","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1016\/S0002-9343(00)00683-5","article-title":"Cyclooxygenase inhibition and thrombogenicity","volume":"110","author":"Catella\u2010Lawson","year":"2001","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0145","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0002-9440(10)65230-3","article-title":"Augmented expression of cyclooxygenase\u20102 in human atherosclerotic lesions","volume":"155","author":"Schonbeck","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/ejvs.2000.1145","article-title":"Expression of cyclo\u2010oxygenase\u20102 in human atherosclerotic carotid arteries","volume":"20","author":"Stemme","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0155","doi-asserted-by":"crossref","first-page":"26D","DOI":"10.1016\/S0002-9149(02)02234-8","article-title":"Cardiovascular pharmacology of nonselective nonsteroidal anti\u2010inflammatory drugs and coxibs: clinical considerations","volume":"89","author":"FitzGerald","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0160","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1073\/pnas.96.9.5292","article-title":"Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate","volume":"96","author":"Xu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0026-895X(24)23038-8","article-title":"Inhibition of cyclooxygenase\u20102 expression by 4\u2010trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2\u2010hydroxy\u20104\u2010trifluoromethylbenzoic acid","volume":"55","author":"Fernandez de Arriba","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0170","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2165\/00003495-200666050-00009","article-title":"Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation","volume":"66","author":"Murdoch","year":"2006","journal-title":"Drugs"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX\u20102 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0180","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1068711","article-title":"Role of prostacyclin in the cardiovascular response to thromboxane A2","volume":"296","author":"Cheng","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.prostaglandins.2006.05.011","article-title":"Cardioprotective prostacyclin signaling in vascular smooth muscle","volume":"82","author":"Fetalvero","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1111\/j.1538-7836.2008.03036.x_bb0190","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJM198312153092410","article-title":"Aspirin as an antithrombotic medication","volume":"309","author":"Marcus","year":"1983","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.03036.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622120283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622120283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.03036.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:47:10Z","timestamp":1761533230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622120283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1538783622120283"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03036.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of triflusal on secondary thrombus growth and vascular cyclooxygenase\u20102","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03036.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}